Our world is experiencing a rise in drug-resistant bacteria, or ‘superbugs’, that pose a significant threat to soldiers and civilians alike, particularly in conflict zones. The main protagonist of these invisible enemies is a strain of Klebsiella, a bacterium that has become so resistant that no modern antibiotic is capable of eradicating it. Juxtaposed with the wartime setting, hospitals are not shielded from this rising menace. The emergence of antimicrobial-resistant organisms (AMRs) is a global healthcare crisis in the making, with the potential to wreak havoc unseen since the dawn of the antibiotic era.
These ‘superbugs’ initially gained attention during the American invasion of Iraq in 2003 when several marines died not from battle injuries, but due to superbug infections after being repatriated. The ensuing years saw the realization that antimicrobial resistance isn’t mere hearsay but a reality we need to urgently contend with. In 2019, the Centers for Disease Control and Prevention (CDC) recognized the increasing danger posed by 18 different AMRs, after noting three million drug-resistant infections per year in the U.S. alone.
As the fight against superbugs struggles to gain political and public traction, resulting from a lack of visible threat, the issue with AMRs is escalating in an under-the-radar fashion. Instead, like climate change, it gradually accumulates momentum, turning into a slow-burning disaster, impossible to ignore when it’s too late.
Recent reports suggest increased AMR levels, especially in conflict-ridden regions such as Ukraine, showing that military conflict amplifies the transmission of superbugs. Once relegated to the battlefield, they are now jumping to civilians in hospitals treating war casualties. As refugees flee war-torn regions, these deadly organisms are primed for wider spread, fueling concerns of global transmission and the possibility of another pandemic. Interestingly, Acinetobacter, an organism responsible for several American soldiers’ deaths during Operation Freedom, is not limited to conflict zones but is burgeoning across the United States.
Given the escalating threat, our approach to combating AMRs is in dire need of reevaluation. Despite awareness, tangible steps towards addressing antibiotic resistance have been limited, raising concerns about the future of healthcare amidst this looming danger. As these ‘superbugs’ persist in their resilience, further research, targeted action, and coordinated public health responses are paramount in arresting the rise of these lethal bacterial strains.